1. Executive Summary |
2. Global Personalized Medicine Market Introduction |
2.1. Global Personalized Medicine Market – Taxonomy |
2.2. Global Personalized Medicine Market –Definitions |
2.2.1. By Product Type |
3. Global Personalized Medicine Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Personalized Medicine Market Dynamic Factors – Impact Analysis |
4. Global Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Personalized Medicine Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Diagnostics |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.1.1 Genetic Testing |
5.1.1.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.1.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3 Market Opportunity Analysis |
5.1.2 DTC Diagnostics |
5.1.2.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3 Market Opportunity Analysis |
5.1.3 Esoteric Lab Services |
5.1.3.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.3.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3 Market Opportunity Analysis |
5.1.4 Esoteric Lab Tests |
5.1.4.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.4.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3 Market Opportunity Analysis |
5.2. Therapeutics |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.1.5 Pharmaceutical |
5.1.5.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.5.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.5.3 Market Opportunity Analysis |
5.1.6 Genomic Medicine |
5.1.6.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.6.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.6.3 Market Opportunity Analysis |
5.1.7 Medical Devices |
5.1.7.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.7.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.7.3 Market Opportunity Analysis |
5.3. Personalized Medical Care |
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.1.8 Telemedicine |
5.1.8.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.8.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.8.3 Market Opportunity Analysis |
5.1.9 Health Information Technology |
5.1.9.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.9.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.9.3 Market Opportunity Analysis |
5.1.10 Disease Management |
5.1.10.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.10.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.10.3 Market Opportunity Analysis |
5.4. Personalized Nutrition & Wellness |
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.1.11 Retail Nutrition |
5.1.11.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.11.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.11.3 Market Opportunity Analysis |
5.1.12 Complementary Medicine |
5.1.12.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.12.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.12.3 Market Opportunity Analysis |
5.1.13 Alternative Medicine |
5.1.13.1 Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.13.2 Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.13.3 Market Opportunity Analysis |
6. Global Personalized Medicine Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. North America |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia-Pacific |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Latin America |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Middle East and Africa |
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Global Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Region, 2022 – 2028 |
7. North America Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
7.1.1. Diagnostics |
7.1.1.1. Genetic Testing |
7.1.1.2. DTC Diagnostics |
7.1.1.3. Esoteric Lab Services |
7.1.1.4. Esoteric Lab Tests |
7.1.2. Therapeutics |
7.1.2.1. Pharmaceutical |
7.1.2.2. Genomic Medicine |
7.1.2.3. Medical Devices |
7.1.3. Personalized Medical Care |
7.1.3.1. Telemedicine |
7.1.3.2. Heath Information Technology |
7.1.3.3. Diseases Management |
7.1.4. Personalized Nutrition & Wellness |
7.1.4.1. Retail Nutrition |
7.1.4.2. Complementary Medicine |
7.1.4.3. Alternative Medicine |
7.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
7.2.1. U.S. |
7.2.2. Canada |
7.3. North America Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Country, 2022 – 2028 |
7.4. North America Personalized Medicine Market Dynamics – Trends |
8. Europe Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Diagnostics |
8.1.1.1. Genetic Testing |
8.1.1.2. DTC Diagnostics |
8.1.1.3. Esoteric Lab Services |
8.1.1.4. Esoteric Lab Tests |
8.1.2. Therapeutics |
8.1.2.1. Pharmaceutical |
8.1.2.2. Genomic Medicine |
8.1.2.3. Medical Devices |
8.1.3. Personalized Medical Care |
8.1.3.1. Telemedicine |
8.1.3.2. Heath Information Technology |
8.1.3.3. Diseases Management |
8.1.4. Personalized Nutrition & Wellness |
8.1.4.1. Retail Nutrition |
8.1.4.2. Complementary Medicine |
8.1.4.3. Alternative Medicine |
8.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Germany |
8.2.2. UK |
8.2.3. France |
8.2.4. Spain |
8.2.5. Italy |
8.2.6. Rest of Europe |
8.3. Europe Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Country, 2022 – 2028 |
8.4. Europe Personalized Medicine Market Dynamics – Trends |
9. Asia-Pacific Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Diagnostics |
9.1.1.1. Genetic Testing |
9.1.1.2. DTC Diagnostics |
9.1.1.3. Esoteric Lab Services |
9.1.1.4. Esoteric Lab Tests |
9.1.2. Therapeutics |
9.1.2.1. Pharmaceutical |
9.1.2.2. Genomic Medicine |
9.1.2.3. Medical Devices |
9.1.3. Personalized Medical Care |
9.1.3.1. Telemedicine |
9.1.3.2. Heath Information Technology |
9.1.3.3. Diseases Management |
9.1.4. Personalized Nutrition & Wellness |
9.1.4.1. Retail Nutrition |
9.1.4.2. Complementary Medicine |
9.1.4.3. Alternative Medicine |
9.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Japan |
9.2.2. China |
9.2.3. India |
9.2.4. Australia & New Zealand |
9.2.5. Rest of Asia-Pacific |
9.3. Asia-Pacific Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Country, 2022 – 2028 |
9.4. Asia-Pacific Personalized Medicine Market Dynamics – Trends |
10. Latin America Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Diagnostics |
10.1.1.1. Genetic Testing |
10.1.1.2. DTC Diagnostics |
10.1.1.3. Esoteric Lab Services |
10.1.1.4. Esoteric Lab Tests |
10.1.2. Therapeutics |
10.1.2.1. Pharmaceutical |
10.1.2.2. Genomic Medicine |
10.1.2.3. Medical Devices |
10.1.3. Personalized Medical Care |
10.1.3.1. Telemedicine |
10.1.3.2. Heath Information Technology |
10.1.3.3. Diseases Management |
10.1.4. Personalized Nutrition & Wellness |
10.1.4.1. Retail Nutrition |
10.1.4.2. Complementary Medicine |
10.1.4.3. Alternative Medicine |
10.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Brazil |
10.2.2. Mexico |
10.2.3. Rest of Latin America |
10.3. Latin America Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Country, 2022 – 2028 |
10.4. Latin America Personalized Medicine Market Dynamics – Trends |
11. Middle East and Africa Personalized Medicine Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Diagnostics |
11.1.1.1. Genetic Testing |
11.1.1.2. DTC Diagnostics |
11.1.1.3. Esoteric Lab Services |
11.1.1.4. Esoteric Lab Tests |
11.1.2. Therapeutics |
11.1.2.1. Pharmaceutical |
11.1.2.2. Genomic Medicine |
11.1.2.3. Medical Devices |
11.1.3. Personalized Medical Care |
11.1.3.1. Telemedicine |
11.1.3.2. Heath Information Technology |
11.1.3.3. Diseases Management |
11.1.4. Personalized Nutrition & Wellness |
11.1.4.1. Retail Nutrition |
11.1.4.2. Complementary Medicine |
11.1.4.3. Alternative Medicine |
11.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Gulf Cooperation Council (GCC) Countries |
11.2.2. Israel |
11.2.3. South Africa |
11.2.4. Rest of MEA |
11.3. MEA Personalized Medicine Market – Opportunity Analysis Index, By Product Type and Country, 2022 – 2028 |
11.4. MEA Personalized Medicine Market Dynamics – Trends |
12. Competition Landscape |
12.1. Strategic Dashboard of Top Market Players |
12.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
12.2.1. GE Healthcare |
12.2.2. Illumina, Inc |
12.2.3. Asuragen, Inc |
12.2.4. Abbott Laboratories |
12.2.5. Dako A/S |
12.2.6. Exact Science Corp |
12.2.7. Biogen, Inc |
12.2.8. Lumenis Ltd |
13. Research Methodology |
14. Key Assumptions and Acronyms |
Reviews
There are no reviews yet.